Evidence for morphine-independent central nervous opioid effects after administration of codeine: contribution of other codeine metabolites.
about
Pharmacokinetics of acetaminophen, codeine, and the codeine metabolites morphine and codeine-6-glucuronide in healthy Greyhound dogsEndogenous opiates and behavior: 2006CYP2D6 in the metabolism of opioids for mild to moderate pain.Differences between opioids: pharmacological, experimental, clinical and economical perspectivesTargeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects.Genetic mutations that prevent pain: implications for future pain medication.Pharmacogenetics of analgesics: toward the individualization of prescription.Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use.Current evidence for a modulation of low back pain by human genetic variants.Pain management in patients with cancer: focus on opioid analgesics.A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project.Pharmacogenomics of opioids and perioperative pain management.The role of cytochrome P450 pharmacogenomics in chronic non-cancer pain patients.Codeine and opioid metabolism: implications and alternatives for pediatric pain management.Effects of three therapeutic doses of codeine/paracetamol on driving performance, a psychomotor vigilance test, and subjective feelings.Influence of (S)-ketamine on human motor cortex excitability.A validated method for simultaneous determination of codeine, codeine-6-glucuronide, norcodeine, morphine, morphine-3-glucuronide and morphine-6-glucuronide in post-mortem blood, vitreous fluid, muscle, fat and brain tissue by LC-MS.Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
P2860
Q24623751-C2E85FCF-5499-47BB-B7F2-DF647EF24917Q28752585-E900518C-96FC-4705-9806-AC77690FAEC0Q34178485-7BA8551B-1DA7-466C-8E29-0D5A8B86DA27Q34272502-851F611C-D6CA-4CBE-9A5C-08CFB242DCC4Q35855634-2B893ABC-7EB9-4388-819E-1470325CCB00Q36111225-4E3BD73F-22BA-4EE9-8AED-7D03E02E1C6AQ37120834-49511859-3E64-42F7-AFAC-FD2C8C116A4FQ37205954-227B5DEF-F4F8-48A4-95ED-9504FC357FF8Q37264538-FBC309F8-8A07-4D95-A050-357EC7E1A203Q37396519-59B4572D-5133-4242-86F5-1E0942B26B53Q37863588-9AF58B40-0970-4931-97E1-26A27E97309AQ37895002-F5C929B7-BA9C-49F6-89F1-20DA600A3AC2Q38061498-0F39A266-8259-4D11-8C5C-6B6BA587E258Q38844220-9929FA0F-2731-48BD-B333-E4A0F4F51F6BQ39190293-0A8BA15F-B9C6-4B86-A8E9-B43C2A0E7AF2Q46055909-77BDBDE0-0813-48A5-95EE-90E07BB457EAQ48112559-FB0C008F-4832-443F-A86B-C2B884F1D4A6Q48392462-58573649-6F9A-47D3-841C-A5DA550CDCAEQ54593894-8138E67E-A0E2-42FE-A5BF-B0BD1AF7FF0E
P2860
Evidence for morphine-independent central nervous opioid effects after administration of codeine: contribution of other codeine metabolites.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Evidence for morphine-independ ...... of other codeine metabolites.
@en
Evidence for morphine-independ ...... of other codeine metabolites.
@nl
type
label
Evidence for morphine-independ ...... of other codeine metabolites.
@en
Evidence for morphine-independ ...... of other codeine metabolites.
@nl
prefLabel
Evidence for morphine-independ ...... of other codeine metabolites.
@en
Evidence for morphine-independ ...... of other codeine metabolites.
@nl
P2093
P50
P1476
Evidence for morphine-independ ...... of other codeine metabolites.
@en
P2093
Gerd Geisslinger
Helmut Schmidt
Maren Rohrbacher
Matthias Schwab
P356
10.1016/J.CLPT.2005.09.005
P407
P577
2006-01-01T00:00:00Z